Apr 27, 2026 Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Feb 09, 2026 XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Jun 12, 2026 • 4:05 PM EDT XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
Apr 27, 2026 • 7:00 AM EDT Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
